Breaking News Instant updates and real-time market news.

DBVT

DBV Technologies

$22.45

-0.57 (-2.48%)

07:13
02/27/18
02/27
07:13
02/27/18
07:13

DBV milk data a 'confidence builder,' says H.C. Wainwright

H.C. Wainwright analyst Andrew Fein says DBV Technologies last night announced positive data from its Phase 2 Miles study evaluating Viaskin Milk against cow milk protein. Solid data in a second indication is a "confidence builder," Fein tells investors in a research note. The data are an important milestone for DBV and epicutaneous immunotherapy, the analyst adds. He believes the "pipeline in a program" thesis, not previously associated with DBV, may be coming into focus. The analyst reiterates a Buy rating on the shares with a $50 price target.

DBVT DBV Technologies
$22.45

-0.57 (-2.48%)

02/20/18
JEFF
02/20/18
NO CHANGE
Target $37
JEFF
Buy
DBV Technologies wins over Aimmune on safety, says Jefferies
Jefferies analyst Eun Yang says that as expected, Aimmune Therapeutics (AIMT) reported "strong" Phase 3 efficacy data for AR101 in peanut allergy. While the Phase 3 designs are different, on efficacy, AR101 is superior to DBV Technologies' (DBVT) Viaskin Peanut (VP), Yang tells investors in a research note. She believes, however, that Viaskin Peanut "wins on safety" and would be a preferred option for children. The analyst expects both products to win FDA approval in the first half of 2019. Yang keeps a Buy rating on DBV shares with a $37 price target. The stock in late morning trading is down 69c to $25.17 while Aimmune is down 6.5% to $34.78.
02/20/18
DBAB
02/20/18
NO CHANGE
Target $30
DBAB
Buy
Deutsche sees room for multiple players in peanut allergy space
Aimmune Therapeutics' (AIMT) top-line results from the Palisade study suggest that AR101 could be an effective treatment for the desensitization of peanut allergy patients to peanut protein, Deutsche Bank analyst Andrew Peters tells investors in a research note. The analyst, however, believes AR101 "continues to be a potentially challenging therapy from a tolerability and safety perspective" with 20.4% of patients discontinuing therapy for all causes. AR101's profile is "far from suggestive of an all-encompassing option for patients," leaving "meaningful opportunity" for other agents, Peters contends. As such, he sees room for both AR101 and DBV Technologies' (DBVT) Viaskin Peanut. The analyst keeps a Buy rating on DBV shares with a $30 price target.
02/26/18
02/26/18
NO CHANGE
Target $37

Buy
DBV Phase II milk data 'highly encouraging,' says Jefferies
Phase II data for DBV Technologies' Viaskin Milk shows significant response in a subgroup of kids with Milk allergy, Jefferies analyst Eun Yang tells investors in a research note. This is "highly encouraging" given the high natural resolution of milk allergy in kids and high placebo rates, Yang contends. She believes Viaskin continues to show safety and high compliance and estimates Viaskin Milk is worth $18 per share if successful in Phase III, versus $3 per share currently. The analyst keeps a Buy rating on DBV Technologies with a $37 price target.
02/27/18
DBAB
02/27/18
NO CHANGE
Target $30
DBAB
Buy
DBV milk allergy data positive, but questions remain, says Deutsche Bank
Last night's positive Phase II data for Viaskin Milk in patients with allergy to cow's milk protein supports the Viaskin platform, but focus remains on DBV Technologies' regulatory process for peanut allergy, Deutsche Bank analyst Andrew Peters says in a research note. The analyst thinks the Miles data are potentially supportive of the overall platform as well as also represent an additional opportunity for the company. He notes that although benefits were observed for children ages 2-11, the treatment did not show a meaningful effect in adolescents, which is similar to the results with Viaskin Peanut. This is potentially indicative of some challenges to the applicability of Viaksin in older patients or indicating the need for further fine-tuning of dose and patch, Peters writes. He reiterates a Buy rating on DBV Technologies with a $30 price target. The analyst believes Viaskin Peanut provides an "attractive risk/benefit" to peanut allergy patients and that the implied risk at current share levels is "overly cautious."

TODAY'S FREE FLY STORIES

02:20
07/18/18
07/18
02:20
07/18/18
02:20
General news
FX Update: The dollar has traded firmer for a second day »

FX Update: The dollar…

01:50
07/18/18
07/18
01:50
07/18/18
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

CCB

Coastal Financial

$0.00

(0.00%)

21:11
07/17/18
07/17
21:11
07/17/18
21:11
Syndicate
Coastal Financial 2.85M share IPO priced at $14.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CRNX

Crinetics

$0.00

(0.00%)

21:08
07/17/18
07/17
21:08
07/17/18
21:08
Syndicate
Crinetics 6M share IPO priced at $17.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

NSTG

NanoString

$12.74

-2.36 (-15.63%)

21:07
07/17/18
07/17
21:07
07/17/18
21:07
Syndicate
NanoString 4M share Secondary priced at $12.50 »

JPMorgan and UBS acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 18

    Jul

ALV

Autoliv

$106.86

1.57 (1.49%)

21:06
07/17/18
07/17
21:06
07/17/18
21:06
Downgrade
Autoliv rating change at Wells Fargo »

Autoliv downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$131.71

3.58 (2.79%)

21:06
07/17/18
07/17
21:06
07/17/18
21:06
Downgrade
Visteon rating change at Wells Fargo »

Visteon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 07

    Aug

ABT

Abbott

$62.84

1.05 (1.70%)

, MS

Morgan Stanley

$49.20

0.29 (0.59%)

20:25
07/17/18
07/17
20:25
07/17/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$62.84

1.05 (1.70%)

MS

Morgan Stanley

$49.20

0.29 (0.59%)

USB

U.S. Bancorp

$51.29

-0.01 (-0.02%)

TXT

Textron

$66.81

0.14 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

ADTN

Adtran

$16.05

0.1 (0.63%)

20:14
07/17/18
07/17
20:14
07/17/18
20:14
Earnings
Adtran reports Q2 adjusted EPS (10c), two estimates (32c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

, ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

20:09
07/17/18
07/17
20:09
07/17/18
20:09
Hot Stocks
FS Bancorp to merge with Anchor Bancorp in $77M deal »

FS Bancorp (FSBW) and…

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$26.41

-1.19 (-4.31%)

20:06
07/17/18
07/17
20:06
07/17/18
20:06
Hot Stocks
Breaking Hot Stocks news story on Canopy Growth  »

Greenstar Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$356.95

0.94 (0.26%)

19:10
07/17/18
07/17
19:10
07/17/18
19:10
Hot Stocks
Boeing awarded $3.9B government contract »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MRTN

Marten Transport

$22.10

(0.00%)

, UAL

United Continental

$72.66

0.38 (0.53%)

19:03
07/17/18
07/17
19:03
07/17/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Martin…

MRTN

Marten Transport

$22.10

(0.00%)

UAL

United Continental

$72.66

0.38 (0.53%)

CSX

CSX

$64.42

0.46 (0.72%)

MLNX

Mellanox

$84.85

0.9 (1.07%)

IBKR

Interactive Brokers

$64.65

1.93 (3.08%)

HCSG

Healthcare Services

$42.38

-0.3297 (-0.77%)

TXN

Texas Instruments

$115.80

1.21 (1.06%)

SAH

Sonic Automotive

$20.45

0.3 (1.49%)

CARA

Cara Therapeutics

$21.60

0.435 (2.06%)

CASI

Casi Pharmaceuticals

$7.26

-0.215 (-2.88%)

TLYS

Tilly's

$15.35

0.21 (1.39%)

CLX

Clorox

$135.00

0.71 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 02

    Aug

  • 26

    Aug

  • 19

    Jul

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:38
07/17/18
07/17
18:38
07/17/18
18:38
Hot Stocks
BHP Billiton sees FY19 copper equivalent output broadly in line with FY18 »

Says expects to achieve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:35
07/17/18
07/17
18:35
07/17/18
18:35
Hot Stocks
BHP Billiton reports Q4 petroleum production 49 MMBOE, down 6% »

Reports Q4 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$135.00

0.71 (0.53%)

18:31
07/17/18
07/17
18:31
07/17/18
18:31
Downgrade
Clorox rating change at Goldman Sachs »

Clorox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

NCS

NCI Building

$20.70

0.15 (0.73%)

18:27
07/17/18
07/17
18:27
07/17/18
18:27
Hot Stocks
NCI Building Systems, Ply Gem Parent to combine in stock-for-stock merger »

NCI Building Systems and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

, AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

18:16
07/17/18
07/17
18:16
07/17/18
18:16
Earnings
America Movil reports Q2 operating profit MXN32.6M, up 4.8% from last year »

Reports Q2 revenue…

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,844.00

21.98 (1.21%)

18:08
07/17/18
07/17
18:08
07/17/18
18:08
Recommendations
Amazon.com analyst commentary at Piper Jaffray »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

, BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

18:06
07/17/18
07/17
18:06
07/17/18
18:06
Hot Stocks
Berkshire Hathaway amends share repurchase program »

The Board of Directors of…

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$60.10

-0.5 (-0.83%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Earnings
Pinnacle Financial reports Q2 EPS $1.15, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Sep

CHDN

Churchill Downs

$304.60

1.1 (0.36%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Hot Stocks
Churchill Downs receives approval to increase historical racing machines »

Churchill Downs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

CE

Celanese

$110.22

1.6 (1.47%)

18:01
07/17/18
07/17
18:01
07/17/18
18:01
Hot Stocks
Celanese announces acetic acid price increases in Asia »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BLK

BlackRock

$504.89

1.14 (0.23%)

17:51
07/17/18
07/17
17:51
07/17/18
17:51
Hot Stocks
BlackRock raises quarterly dividend to $3.13 from $2.88 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRNA

Dicerna

$12.47

0.57 (4.79%)

17:45
07/17/18
07/17
17:45
07/17/18
17:45
Conference/Events
Dicerna management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.